James Mitchell Leiper

Title: James Mitchell Leiper: Innovator in Guanidine Derivatives

Introduction

James Mitchell Leiper is a notable inventor based in London, GB. He has made significant contributions to the field of medicinal chemistry, particularly through his work on Guanidine derivatives. His innovative approach has led to advancements in the treatment of diseases affected by DDAH.

Latest Patents

Leiper holds a patent for Guanidine derivatives as inhibitors of DDAH. The patent describes compounds of formula (I) that have been found to be useful as inhibitors of DDAH. This invention provides the use of a compound of formula (I), or a pharmaceutically acceptable salt thereof, in the manufacture of a medicament for treating diseases whose pathology is influenced by DDAH.

Career Highlights

James Mitchell Leiper is associated with UCL Business Plc, where he continues to develop his research and innovations. His work has garnered attention for its potential impact on therapeutic applications.

Collaborations

Leiper has collaborated with esteemed colleagues such as Patrick John Thompson Vallance and David Lawrence Selwood. These partnerships have enriched his research and expanded the scope of his inventions.

Conclusion

James Mitchell Leiper's contributions to the field of medicinal chemistry, particularly through his patent on Guanidine derivatives, highlight his role as an innovator. His work continues to pave the way for advancements in medical treatments.